Antioxidant Effect of Hydroxytyrosol, Hydroxytyrosol Acetate and Nitrohydroxytyrosol in a Rat MPP+ Model of Parkinson's Disease

Neurochem Res. 2021 Nov;46(11):2923-2935. doi: 10.1007/s11064-021-03379-x. Epub 2021 Jul 14.

Abstract

3,4-Dihydroxyphenyl ethanol, known as hydroxytyrosol (HTy), is a phenylpropanoid found in diverse vegetable species. Several studies have demonstrated that HTy is a potent antioxidant. Thus, our study is aimed to evaluate the antioxidant effect of HTy and its derivatives, hydroxytyrosol acetate (HTyA) and nitrohydroxytyrosol (HTyN), in a model of oxidative stress induced by 1-methyl-4-phenylpyridinium (MPP+) in rats. Rats were administered intravenously (i.v.) in the tail with 1 mL saline solution or polyphenol compound (1.5 mg/kg) 5 min before intrastriatal infusion of 10 µg MPP+/8 µL. We found that rats injured with MPP+, pretreatment with HTy, HTyA or HTyN significantly decreased ipsilateral turns. This result was consistent with a significant preservation of striatal dopamine levels and decreased lipid fluorescence products (LFP), a marker of oxidative stress. Brain GSH/GSSG ratio, from rats pretreated with HTy or HTyN showed a significant preservation of that marker, decreased as a consequence of MPP+-induced oxidative damage. These results show an antioxidant effect of HTy, HTyA and HTyN in the MPP+ model of Parkinson's disease in the rat.

Keywords: Dopamine; GSH/GSSG; Hydroxytyrosol; Lipid peroxidation; Oxidative stress; Parkinson’s disease.

MeSH terms

  • 1-Methyl-4-phenylpyridinium / toxicity*
  • Acetates / administration & dosage*
  • Administration, Intravenous
  • Animals
  • Antioxidants / administration & dosage*
  • Catechols / administration & dosage*
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism
  • Dopamine / metabolism
  • Lipid Peroxidation / drug effects
  • Lipid Peroxidation / physiology
  • Male
  • Oxidative Stress / drug effects
  • Oxidative Stress / physiology
  • Parkinsonian Disorders / chemically induced*
  • Parkinsonian Disorders / metabolism*
  • Parkinsonian Disorders / prevention & control
  • Phenylethyl Alcohol / administration & dosage
  • Phenylethyl Alcohol / analogs & derivatives*
  • Rats
  • Rats, Wistar
  • Treatment Outcome

Substances

  • Acetates
  • Antioxidants
  • Catechols
  • hydroxytyrosyl acetate
  • 3,4-dihydroxyphenylethanol
  • Phenylethyl Alcohol
  • 1-Methyl-4-phenylpyridinium
  • Dopamine

Grants and funding